|  |  |  |  |  |
| Company | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. |
| Item | MAXITROL® Ophthalmic Suspension | CORTISPORIN* Ophthalmic Suspension | CORTISPORIN* Otic Suspension | FML* Ophthalmic Suspension | MAXITROL® Ophthalmic Oin™ent |
| Price | Inquire | Inquire | Inquire | Inquire | Inquire |
| Description | Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic suspension is a multiple dose anti-infective steroid combination in sterile suspension form for topical applications. | Neomycin and Polymyxin B Sulfates and Hydrocortisone ophthalmic suspension is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use. | Neomycin and Polymyxin B Sulfates and Hydrocortisone otic suspension, USP is a sterile antibacterial and anti-inflammatory suspension for otic use. | Fluorometholone ophthalmic suspension USP, 0.1% is a topical anti-inflammatory agent for ophthalmic use. | Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications. |
| Approval | USA and Worldwide | USA and Worldwide | USA and Worldwide | USA and Worldwide | USA and Worldwide |
| Type | Suspension | Suspension | Otic Suspension | Suspension | Ointment |
| Product Number | 61314-630-06 | 61314-641-75 | 61314-645-10 | 61314-328-05 | 61314-631-36 |
| Size | 5 ml | 7.5 ml | 10 ml | 5 ml | 3.5 gm |
| Content | Dexamethasone + Neomycin | Hydrocortisone + Neomycin | Hydrocortisone + Neomycin | Fluorometholone | Dexamethasone + Neomycin |
| Strength | Dexamethasone 0.1% + Neomycin 3.5 mg | Hydrocortisone 1% + Neomycin 3.5 mg | Hydrocortisone 1% + Neomycin 3.5 mg | 0.1% | Dexamethasone 0.1% + Neomycin 3.5 mg |
| Supplied as | Plastic 'Drop-Tainer' dispensers | Drop-Tainer' bottle | Bottle with sterilized dropper | Plastic dropper bottles | 3.5 gm ointment tube |
| Get quote | Inquire | Inquire | Inquire | Inquire | Inquire |